Barclays raised the firm’s price target on NOV Inc. (NOV) to $14 from $11 and keeps an Underweight rating on the shares. The firm says the company’s equipment segment led the way this quarter on higher backlog conversion and an “impressive” order book.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOV:
